Multiomics Market by Offerings [Product, Service], Method, Technology [Sequencing, Proteomics ], Workflow, Application, Competition

Description

List of Tables

The global multiomics market is estimated to reach USD 5.70 billion by 2031 from USD 3.18 billion in 2026, at a CAGR of 12.3% during the forecast period. The global multiomics market is expected to witness significant growth through 2031, driven by the increasing adoption of integrated genomic, transcriptomic, proteomic, metabolomic, and epigenomic profiling technologies.

Scope of the Report
Years Considered for the Study	2026-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD billion)
Segments	Offering, Method, Technology, Workflow, Application, and End User
Regions covered	North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa

The market expansion is supported by rising demand for comprehensive biological characterization in oncology, drug discovery, precision medicine, and translational research. Advancements in single-cell analysis, spatial omics, next-generation sequencing, mass spectrometry, and AI-enabled bioinformatics platforms are further accelerating adoption. However, high technology costs, complex data integration requirements, and the need for specialized computational expertise may limit adoption across resource-constrained research environments.

"The product segment accounted for the largest share by offering in the multiomics market in 2025."

Based on offering, the multiomics market is segmented into products and services. In 2025, products accounted for the largest share of the market, driven by widespread adoption of sequencing platforms, analytical instruments, assay kits, reagents, consumables, and software solutions required throughout multiomics workflows. These products support sample preparation, sequencing, characterization, and data analysis activities across pharmaceutical companies, biotechnology firms, academic institutions, and research laboratories. The services segment is expected to grow at the fastest rate during the forecast period, supported by increasing outsourcing of complex multiomics profiling, bioinformatics analysis, and integrated omics interpretation to specialized service providers.

"Single-cell omics accounted for the largest share, by method, in the multiomics market in 2025."

Based on method, the multiomics market is segmented into epigenomics, single-cell omics, spatial omics, long-read & long-range sequencing, proteomics, and other methods. Single-cell omics accounted for the largest share in 2025 due to its ability to characterize cellular heterogeneity and molecular interactions at individual cell resolution. Increasing adoption in oncology, immunology, developmental biology, and drug discovery applications continues to support its leading position. Spatial omics is expected to register the fastest growth during the forecast period, driven by increasing demand for technologies that preserve tissue architecture while enabling simultaneous molecular profiling.

"The Asia Pacific is growing at the highest CAGR in the multiomics market from 2026 to 2031."

The multiomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. During the forecast period, the Asia Pacific region is expected to register the highest CAGR, driven by increasing investments in genomics and life sciences research, expanding precision medicine initiatives, and the growing adoption of next-generation sequencing (NGS), single-cell, spatial biology, and high-resolution mass spectrometry technologies. Regional growth is further supported by rising government funding for omics research, rapid expansion of biotechnology and pharmaceutical R&D, increasing availability of advanced research infrastructure, and the growing presence of contract research organizations (CROs) and genomic service providers. Additionally, the strong presence of leading regional companies such as BGI Genomics and Novogene, along with continued investments by global multiomics technology providers, is strengthening the region's capabilities in multiomics research, biomarker discovery, and precision medicine applications, making Asia Pacific the fastest-growing market during the forecast period.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side - 70% and Demand Side - 30%
By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
By Designation: CXOs and Directors - 30%, Managers - 45%, and Others - 25%
By Region: North America - 40%, Europe - 25%, Asia Pacific - 20%, Latin America - 10%, and the Middle East & Africa - 5%

List of Companies Profiled in the Report

10x Genomics, Inc.
Thermo Fisher Scientific Inc.
Illumina, Inc.
Oxford Nanopore Technologies plc
Bruker
PacBio
Danaher Corporation
Vizgen Corporation
Agilent Technologies, Inc
Biognosys AG
Merck KGaA
QIAGEN N.V.
Revvity, Inc.
Waters Corporation
Syngene International
Bio-Rad Laboratories, Inc
Takara Bio Inc
Metabolon, Inc
BGI Genomics Co., Ltd

Research Coverage

This research report categorizes the multiomics market by offering, method, technology, workflow, application, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints, influencing the growth of the multiomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product portfolio, key strategies such as product and service approvals and launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the multiomics market. This report covers competitive analysis of top players and upcoming startups in the multiomics market ecosystem.

Key Benefits of Buying the Report

The report will help market leaders/new entrants by providing the closest approximations of revenue for the overall multiomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business more effectively and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide information on key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

Analysis of key drivers (rising adoption of multiomics in precision medicine and disease stratification, rapid adoption of single-cell and spatial multiomics, increasing accessibility of high-quality integrated omics data for research, and advances in AI, machine learning, and cloud bioinformatics for cross-omics data interpretation), restraints (complexity of multiomics data integration and standardization, and high costs associated with multiomics technologies limiting widespread adoption), opportunities (growing adoption of spatial proteomics for tissue-context analysis and biomarker discovery, and increasing emergence of single-cell proteomics for high-resolution cellular profiling), and challenges (lack of standardization across multiomics workflows) influencing the growth of multiomics market
Product Development/Innovation: Detailed insights on newly launched products of the multiomics market
Market Development: Comprehensive information about lucrative markets - the report analyses the Multiomics market across varied regions
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the multiomics market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as 10x Genomics, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Oxford Nanopore Technologies plc (UK), and Bruker Corporation (US), among others

Product Code: BT 10585

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 MULTIOMICS MARKET OVERVIEW
3.2 MULTIOMICS MARKET, BY OFFERING AND REGION
3.3 MULTIOMICS MARKET: GEOGRAPHIC SNAPSHOT
3.4 MULTIOMICS MARKET, BY OFFERING

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
  - 4.2.1.1 Rising use of multiomics in precision medicine and disease stratification
  - 4.2.1.2 Rapid adoption of single-cell and spatial multiomics
  - 4.2.1.3 Increasing accessibility of high-quality, integrated omics data for research
  - 4.2.1.4 AI, machine learning, and cloud bioinformatics improving cross-omics interpretation
- 4.2.2 RESTRAINTS
  - 4.2.2.1 Complexity of multiomics data integration and standardization
  - 4.2.2.2 High costs constrain technology adoption
- 4.2.3 OPPORTUNITIES
  - 4.2.3.1 Growing adoption of spatial proteomics for tissue-context analysis and biomarker discovery
  - 4.2.3.2 Increasing emergence of single-cell proteomics for high-resolution characterization of cellular profiles
- 4.2.4 CHALLENGES
  - 4.2.4.1 Lack of standardization across multiomics workflows
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 BARGAINING POWER OF SUPPLIERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
- 5.2.4 TRENDS IN GLOBAL PHARMACEUTICAL INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY TYPE (2023-2025)
- 5.5.2 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY TYPE, 2023-2025
- 5.5.3 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025
5.6 TRADE ANALYSIS
- 5.6.1 IMPORT DATA FOR HS CODE 9027
- 5.6.2 EXPORT DATA FOR HS CODE 9027
- 5.6.3 IMPORT VOLUME FOR HS CODE 9027
- 5.6.4 EXPORT VOLUME FOR HS CODE 9027
5.7 KEY CONFERENCES & EVENTS
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.9 INVESTMENT/FUNDING ACTIVITY
5.10 CASE STUDY ANALYSIS
- 5.10.1 ADVANCED MULTIOMICS PROFILING TO SUPPORT PRECISION MEDICINE ADOPTION
- 5.10.2 INTEGRATED LONG-READ SEQUENCING TO SUPPORT MULTIOMICS RESEARCH
- 5.10.3 MULTIOMICS DATA INTEGRATION TO ACCELERATE BIOMARKER DISCOVERY
5.11 IMPACT OF 2025 US TARIFFS-MULTIOMICS MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 KEY TARIFF RATES
- 5.11.3 PRICE IMPACT ANALYSIS
- 5.11.4 IMPACT ON COUNTRIES/REGIONS
  - 5.11.4.1 North America
  - 5.11.4.2 Europe
  - 5.11.4.3 Asia Pacific
- 5.11.5 IMPACT ON END-USE INDUSTRIES
  - 5.11.5.1 Pharmaceutical and biotechnology companies
  - 5.11.5.2 Hospitals and diagnostic laboratories
  - 5.11.5.3 Academic & research institutes
  - 5.11.5.4 CROs & CDMOs

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

6.1 KEY TECHNOLOGIES
- 6.1.1 SINGLE-CELL MULTIOMICS CO-ASSAYS AND SCALABLE BARCODING
- 6.1.2 SPATIAL MULTIOMICS AND SUBCELLULAR TISSUE MAPPING
- 6.1.3 HIGH-PLEX PROTEOGENOMICS AND NGS/PCR-BASED PROTEIN READOUTS
6.2 ADJACENT TECHNOLOGIES
- 6.2.1 MICROARRAYS AND HYBRIDIZATION-BASED PROFILING
- 6.2.2 DIGITAL PATHOLOGY AND ADVANCED SPATIAL IMAGING
6.3 COMPLEMENTARY TECHNOLOGIES
- 6.3.1 MICROFLUIDICS, CELL/NUCLEI CAPTURE, AND SAMPLE INDEXING
- 6.3.2 HIGH-RESOLUTION MASS SPECTROMETRY AND ION MOBILITY
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.5 PATENT ANALYSIS
- 6.5.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR MULTIOMICS PATENTS, 2015-2025
6.6 FUTURE APPLICATIONS
6.7 IMPACT OF AI/GEN AI ON MULTIOMICS MARKET
- 6.7.1 TOP USE CASES AND MARKET POTENTIAL
- 6.7.2 BEST PRACTICES IN AI-ENABLED MULTIOMICS WORKFLOWS
- 6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN MULTIOMICS MARKET
- 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
- 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MULTIOMICS MARKET

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 MULTIOMICS MARKET, BY OFFERING

8.1 INTRODUCTION
8.2 PRODUCTS
- 8.2.1 CONSUMABLES
  - 8.2.1.1 Increasing experiment volumes, higher multiplexing, and recurring reagent requirements support growth
  - 8.2.1.2 Assay kits & reagents
    - 8.2.1.2.1 Recurring assay consumption, higher multiplexing, and improved low-input performance drive market growth
  - 8.2.1.3 Other consumables
- 8.2.2 INSTRUMENTS & SOFTWARE
  - 8.2.2.1 Integrated multiomics platforms, automated workflows, and AI-enabled data interpretation strengthen demand
8.3 SERVICES
- 8.3.1 RISING OUTSOURCING OF SPECIALIZED PROFILING AND INTERPRETATION TO DRIVE MARKET GROWTH

9 MULTIOMICS MARKET, BY TECHNOLOGY

9.1 INTRODUCTION
9.2 SEQUENCING
- 9.2.1 LONG-READ SEQUENCING
  - 9.2.1.1 Nanopore sequencing
    - 9.2.1.1.1 Real-time native-molecule analysis, scalable platforms, and integrated genomic-epigenomic readouts are accelerating nanopore sequencing adoption
  - 9.2.1.2 SMRT Sequencing
    - 9.2.1.2.1 High-accuracy HiFi reads and lower sequencing cost to expand SMRT-based multiomics
- 9.2.2 OTHER SEQUENCING TECHNOLOGIES
9.3 PROTEOMICS
- 9.3.1 ADVANCES IN HIGH-SENSITIVITY MASS SPECTROMETRY, SINGLE-CELL ANALYSIS, AND SCALABLE PROTEIN QUANTIFICATION ARE ACCELERATING PROTEOMICS ADOPTION IN MULTIOMICS RESEARCH
9.4 OTHER TECHNOLOGIES

10 MULTIOMICS MARKET, BY METHOD

10.1 INTRODUCTION
10.2 SINGLE-CELL OMICS
- 10.2.1 IMPROVED CELL CAPTURE AND GROWING DEMAND TO RESOLVE CELLULAR HETEROGENEITY DRIVE MARKET GROWTH
- 10.2.2 SINGLE-CELL TRANSCRIPTOMICS
  - 10.2.2.1 Higher sample throughput, improved cell recovery, and compatibility with fixed clinical samples are expanding single-cell transcriptomics
- 10.2.3 SINGLE-CELL EPIGENOMICS
  - 10.2.3.1 Growing interest in gene regulation, chromatin state, and treatment resistance is accelerating single-cell epigenomics research
- 10.2.4 SINGLE-CELL PROTEOMICS
  - 10.2.4.1 Ultrasensitive mass spectrometry and higher-throughput protein quantification expanding functional analysis at single-cell resolution
- 10.2.5 SINGLE-CELL GENOMICS
  - 10.2.5.1 Improved detection of clonal variation and simultaneous genotype-phenotype analysis are driving single-cell genomics adoption
- 10.2.6 OTHER SINGLE-CELL OMICS
10.3 PROTEOMICS
- 10.3.1 MS-BASED PROTEOMICS
  - 10.3.1.1 Data-independent acquisition and improved quantitative depth to sustain MS-based proteomics leadership
- 10.3.2 NGS-BASED PROTEOMICS
  - 10.3.2.1 Sequencing readouts and ultra-high-plex panels to make NGS-based proteomics the fastest-growing proteomics method
- 10.3.3 PCR-BASED PROTEOMICS
  - 10.3.3.1 Sensitive proximity-amplification assays to support targeted, low-volume protein profiling
- 10.3.4 OTHER PROTEOMICS METHODS
10.4 SPATIAL OMICS
- 10.4.1 SPATIAL TRANSCRIPTOMICS
  - 10.4.1.1 Whole-transcriptome tissue mapping and higher resolution to sustain spatial transcriptomics leadership
- 10.4.2 SPATIAL PROTEOMICS
  - 10.4.2.1 Higher-plex imaging and tissue phenotyping to accelerate spatial proteomics adoption
- 10.4.3 SPATIAL EPIGENOMICS
  - 10.4.3.1 Mapping regulatory states within tissue to expand spatial epigenomics from early research applications
- 10.4.4 SPATIAL GENOMICS
  - 10.4.4.1 In situ variant and copy-number mapping to support spatial genomics growth
- 10.4.5 OTHER SPATIAL OMICS
10.5 LONG-READ & LONG-RANGE SEQUENCING
- 10.5.1 IMPROVED STRUCTURAL VARIANT, ISOFORM, AND NATIVE EPIGENETIC RESOLUTION TO ACCELERATE ADOPTION
- 10.5.2 LONG-READ SEQUENCING
  - 10.5.2.1 Higher accuracy and throughput to ensure market leadership
- 10.5.3 LONG-RANGE SEQUENCING
  - 10.5.3.1 Genome mapping and linked information to improve structural and haplotype characterization
- 10.5.4 OTHER LONG-READ & LONG-RANGE SEQUENCING METHODS
10.6 EPIGENOMICS
- 10.6.1 SEQUENCING-BASED EPIGENOMICS
  - 10.6.1.1 DNA methylation sequencing
    - 10.6.1.1.1 Genome-wide and targeted methylation analysis to sustain the largest sequencing-based epigenomics share
  - 10.6.1.2 Chromatin accessibility sequencing
    - 10.6.1.2.1 ATAC-seq adoption and regulatory element mapping to make accessibility profiling the fastest-growing epigenomics method
  - 10.6.1.3 Histone modification profiling
    - 10.6.1.3.1 Lower-input chromatin profiling to broaden analysis of histone-associated regulatory states
  - 10.6.1.4 Chromatin interaction analysis
    - 10.6.1.4.1 3D genome mapping to connect distal regulatory elements with gene activity
- 10.6.2 OTHER EPIGENOMICS METHODS
10.7 OTHER METHODS

11 MULTIOMICS MARKET, BY WORKFLOW

11.1 INTRODUCTION
11.2 SEQUENCING & ANALYSIS/SAMPLE CHARACTERIZATION
- 11.2.1 HIGHER-THROUGHPUT MOLECULAR PROFILING AND INCREASINGLY SENSITIVE ANALYTICAL PLATFORMS TO STRENGTHEN SEQUENCING AND SAMPLE CHARACTERIZATION WORKFLOWS
11.3 SAMPLE PREPARATION
- 11.3.1 IMPROVED SAMPLE PRESERVATION, CELL CAPTURE, AUTOMATION, AND MULTIPLEXING TO EXPAND SCALE AND REPRODUCIBILITY OF MULTIOMICS STUDIES
11.4 DATA VISUALIZATION & ANALYSIS
- 11.4.1 AI-ENABLED ANALYTICS AND MULTIMODAL INTEGRATION TO ACCELERATE CONVERSION OF COMPLEX MULTIOMICS DATA INTO BIOLOGICAL INSIGHTS

12 MULTIOMICS MARKET, BY APPLICATION

12.1 INTRODUCTION
12.2 ONCOLOGY
- 12.2.1 GROWING USE OF TUMOR MULTIOMICS FOR BIOMARKER DISCOVERY AND PATIENT STRATIFICATION DRIVES MARKET LEADERSHIP
12.3 DRUG DISCOVERY & DEVELOPMENT
- 12.3.1 DATA-DRIVEN TARGET SELECTION AND MECHANISM STUDIES TO MAKE DRUG DISCOVERY FASTEST-GROWING APPLICATION
12.4 IMMUNOLOGY
- 12.4.1 LARGE-SCALE IMMUNE PROFILING PROGRAMS TO ACCELERATE MULTIMODAL IMMUNOLOGY RESEARCH
12.5 PRECISION MEDICINE
- 12.5.1 INTEGRATED MOLECULAR AND CLINICAL DATA TO EXPAND PATIENT-SPECIFIC DECISION SUPPORT
12.6 BIOMARKER DISCOVERY
- 12.6.1 CROSS-OMICS VALIDATION TO IMPROVE BIOMARKER ROBUSTNESS AND CLINICAL RELEVANCE
12.7 CELL BIOLOGY
- 12.7.1 HIGHER-RESOLUTION PROFILING OF CELL STATES, INTERACTIONS, AND DIFFERENTIATION PROCESSES EXPANDING ROLE OF MULTIOMICS IN CELL BIOLOGY
12.8 TRANSLATIONAL RESEARCH
- 12.8.1 IMPROVED ANALYSIS OF SPECIMENS AND MORE SCALABLE SPATIAL WORKFLOWS ACCELERATE TRANSLATION OF MULTIOMICS DISCOVERIES INTO THERAPEUTIC RESEARCH
12.9 NEUROLOGY
- 12.9.1 BRAIN-CELL ATLASES AND SPATIALLY RESOLVED MOLECULAR PROFILING DRIVE UNDERSTANDING OF NEUROLOGICAL DISEASE PROGRESSION AND THERAPEUTIC TARGETS
12.10 CLINICAL DIAGNOSTICS
- 12.10.1 GROWING CLINICAL SEQUENCING INFRASTRUCTURE TO SUPPORT MULTIOMICS-RELATED DIAGNOSTIC ADOPTION
12.11 OTHER APPLICATIONS

13 MULTIOMICS MARKET, BY END USER

13.1 INTRODUCTION
13.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 13.2.1 EXPANDING PRECISION MEDICINE INITIATIVES ACCELERATE MULTIOMICS ADOPTION
13.3 ACADEMIC & RESEARCH INSTITUTES
- 13.3.1 GROWING RESEARCH FUNDING DRIVING MULTIOMICS USAGE AMONG ACADEMIC AND RESEARCH INSTITUTES
13.4 CROS & CDMOS
- 13.4.1 OUTSOURCING OF COMPLEX PROFILING AND ANALYTICS TO MAKE CROS & CDMOS THE FASTEST-GROWING END USERS
13.5 HOSPITALS & DIAGNOSTIC/CLINICAL LABORATORIES
- 13.5.1 CLINICAL EVIDENCE AND WORKFLOW STANDARDIZATION TO SUPPORT MEASURED ADOPTION IN HOSPITALS AND LABORATORIES

14 MULTIOMICS MARKET, BY REGION

14.1 INTRODUCTION
14.2 NORTH AMERICA
- 14.2.1 US
  - 14.2.1.1 Regulatory acceptance, clinically integrated molecular testing, and population-scale health datasets accelerate multiomics adoption
- 14.2.2 CANADA
  - 14.2.2.1 Population-scale precision health initiatives expand integration capacity
14.3 EUROPE
- 14.3.1 GERMANY
  - 14.3.1.1 Clinical integration of genome sequencing and strong translational research networks drive market growth
- 14.3.2 UK
  - 14.3.2.1 Population-scale multimodal datasets, NHS integration, and industry-backed biomarker programs propel market growth
- 14.3.3 FRANCE
  - 14.3.3.1 Standardized precision-medicine pathways and strong oncology research networks drive market
- 14.3.4 ITALY
  - 14.3.4.1 Shared research infrastructure widening access beyond leading academic centers
- 14.3.5 SPAIN
  - 14.3.5.1 Hospital-linked genomics programs support steady adoption of integrated profiling
- 14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
- 14.4.1 CHINA
  - 14.4.1.1 Large-scale genomic initiatives and rapid adoption of precision medicine technologies drive growth
- 14.4.2 JAPAN
  - 14.4.2.1 Mature biobanks and pharmaceutical research support stable, high-value adoption
- 14.4.3 SOUTH KOREA
  - 14.4.3.1 National bio-data infrastructure and digital-health capabilities accelerate multiomics use
- 14.4.4 INDIA
  - 14.4.4.1 GenomeIndia and expanding translational capacity propel rapid growth in Indian multiomics market
- 14.4.5 AUSTRALIA
  - 14.4.5.1 Mission-led genomics investment strengthens clinical translation and data integration
- 14.4.6 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
- 14.5.1 BRAZIL
  - 14.5.1.1 Growing genomics infrastructure and increasing precision medicine adoption drive market growth
- 14.5.2 REST OF LATIN AMERICA
14.6 MIDDLE EAST
- 14.6.1 GCC COUNTRIES
  - 14.6.1.1 Saudi Arabia
    - 14.6.1.1.1 Rising healthcare expenditure, expanding genomics research, and investments in precision medicine to propel market
  - 14.6.1.2 UAE
    - 14.6.1.2.1 Large-scale citizen sequencing moves genomics toward preventive and personalized care
  - 14.6.1.3 Rest of GCC Countries
- 14.6.2 REST OF MIDDLE EAST
14.7 AFRICA
- 14.7.1 DESPITE EMERGING OPPORTUNITIES, GROWTH REMAINS SLOW DUE TO LIMITED ACCESS TO ADVANCED TECHNOLOGY AND INADEQUATE FUNDING & WORKFORCE

15 COMPETITIVE LANDSCAPE

15.1 OVERVIEW
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MULTIOMICS MARKET
15.3 REVENUE ANALYSIS, 2021-2025
15.4 MARKET SHARE ANALYSIS, 2025
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 15.5.1 STARS
- 15.5.2 EMERGING LEADERS
- 15.5.3 PERVASIVE PLAYERS
- 15.5.4 PARTICIPANTS
- 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
  - 15.5.5.1 Company footprint
  - 15.5.5.2 Region footprint
  - 15.5.5.3 Offering footprint
  - 15.5.5.4 Technology footprint
  - 15.5.5.5 Workflow footprint
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 15.6.1 PROGRESSIVE COMPANIES
- 15.6.2 RESPONSIVE COMPANIES
- 15.6.3 DYNAMIC COMPANIES
- 15.6.4 STARTING BLOCKS
- 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
  - 15.6.5.1 Detailed list of key startups/SMEs
  - 15.6.5.2 Competitive benchmarking of key startups/SMEs
15.7 COMPANY VALUATION AND FINANCIAL METRICS
- 15.7.1 COMPANY VALUATION
- 15.7.2 FINANCIAL METRICS
15.8 BRAND/PRODUCT COMPARISON
15.9 COMPETITIVE SCENARIO
- 15.9.1 PRODUCT & SERVICE LAUNCHES
- 15.9.2 DEALS
- 15.9.3 EXPANSIONS

16 COMPANY PROFILES

16.1 KEY COMPANIES
- 16.1.1 10X GENOMICS
  - 16.1.1.1 Business overview
  - 16.1.1.2 Products & services offered
  - 16.1.1.3 Recent developments
    - 16.1.1.3.1 Product & service launches
    - 16.1.1.3.2 Deals
  - 16.1.1.4 MnM view
    - 16.1.1.4.1 Key strengths
    - 16.1.1.4.2 Strategic choices
    - 16.1.1.4.3 Weaknesses and competitive threats
- 16.1.2 THERMO FISHER SCIENTIFIC INC.
  - 16.1.2.1 Business overview
  - 16.1.2.2 Products & services offered
  - 16.1.2.3 Recent developments
    - 16.1.2.3.1 Product & service launches
    - 16.1.2.3.2 Deals
  - 16.1.2.4 MnM view
    - 16.1.2.4.1 Key strengths
    - 16.1.2.4.2 Strategic choices
    - 16.1.2.4.3 Weaknesses and competitive threats
- 16.1.3 ILLUMINA, INC.
  - 16.1.3.1 Business overview
  - 16.1.3.2 Products & services offered
  - 16.1.3.3 Recent developments
    - 16.1.3.3.1 Product & service launches
    - 16.1.3.3.2 Deals
  - 16.1.3.4 MnM view
    - 16.1.3.4.1 Key strengths
    - 16.1.3.4.2 Strategic choices
    - 16.1.3.4.3 Weaknesses and competitive threats
- 16.1.4 OXFORD NANOPORE TECHNOLOGIES PLC
  - 16.1.4.1 Business overview
  - 16.1.4.2 Products & services offered
  - 16.1.4.3 Recent developments
    - 16.1.4.3.1 Deals
    - 16.1.4.3.2 Expansions
  - 16.1.4.4 MnM view
    - 16.1.4.4.1 Key strengths
    - 16.1.4.4.2 Strategic choices
    - 16.1.4.4.3 Weaknesses and competitive threats
- 16.1.5 BRUKER
  - 16.1.5.1 Business overview
  - 16.1.5.2 Products & services offered
  - 16.1.5.3 Recent developments
    - 16.1.5.3.1 Product & service launches
    - 16.1.5.3.2 Deals
  - 16.1.5.4 MnM view
    - 16.1.5.4.1 Key strengths
    - 16.1.5.4.2 Strategic choices
    - 16.1.5.4.3 Weaknesses and competitive threats
- 16.1.6 PACBIO
  - 16.1.6.1 Business overview
  - 16.1.6.2 Products & services offered
  - 16.1.6.3 Recent developments
    - 16.1.6.3.1 Product & service launches
    - 16.1.6.3.2 Deals
- 16.1.7 DANAHER CORPORATION
  - 16.1.7.1 Business overview
  - 16.1.7.2 Products & services offered
  - 16.1.7.3 Recent developments
    - 16.1.7.3.1 Product & service launches
    - 16.1.7.3.2 Deals
- 16.1.8 VIZGEN, INC.
  - 16.1.8.1 Business overview
  - 16.1.8.2 Products & services offered
  - 16.1.8.3 Recent developments
    - 16.1.8.3.1 Deals
- 16.1.9 AGILENT TECHNOLOGIES, INC.
  - 16.1.9.1 Business overview
  - 16.1.9.2 Products & services offered
  - 16.1.9.3 Recent developments
    - 16.1.9.3.1 Product & service launches
    - 16.1.9.3.2 Deals
    - 16.1.9.3.3 Expansions
- 16.1.10 BIOGNOSYS
  - 16.1.10.1 Business overview
  - 16.1.10.2 Products & services offered
  - 16.1.10.3 Recent developments
    - 16.1.10.3.1 Deals
- 16.1.11 MERCK KGAA
  - 16.1.11.1 Business overview
  - 16.1.11.2 Products & services offered
  - 16.1.11.3 Recent developments
    - 16.1.11.3.1 Expansions
- 16.1.12 QIAGEN N.V.
  - 16.1.12.1 Business overview
  - 16.1.12.2 Products & services offered
  - 16.1.12.3 Recent developments
    - 16.1.12.3.1 Product & service launches
    - 16.1.12.3.2 Deals
    - 16.1.12.3.3 Expansions
- 16.1.13 REVVITY, INC.
  - 16.1.13.1 Business overview
  - 16.1.13.2 Products & services offered
  - 16.1.13.3 Recent developments
    - 16.1.13.3.1 Product & service launches
    - 16.1.13.3.2 Deals
- 16.1.14 WATERS CORPORATION
  - 16.1.14.1 Business overview
  - 16.1.14.2 Products & services offered
  - 16.1.14.3 Recent developments
    - 16.1.14.3.1 Product & service launches
    - 16.1.14.3.2 Deals
    - 16.1.14.3.3 Expansions
- 16.1.15 BIO-RAD LABORATORIES, INC.
  - 16.1.15.1 Business overview
  - 16.1.15.2 Products & services offered
  - 16.1.15.3 Recent developments
    - 16.1.15.3.1 Product & service launches
    - 16.1.15.3.2 Deals
- 16.1.16 TAKARA BIO INC.
  - 16.1.16.1 Business overview
  - 16.1.16.2 Products & services offered
  - 16.1.16.3 Recent developments
    - 16.1.16.3.1 Expansions
- 16.1.17 METABOLON, INC.
  - 16.1.17.1 Business overview
  - 16.1.17.2 Products & services offered
  - 16.1.17.3 Recent developments
    - 16.1.17.3.1 Product & service launches
16.2 OTHER PLAYERS
- 16.2.1 BGI GENOMICS CO., LTD.
- 16.2.2 NOVOGENE CO., LTD.
- 16.2.3 AZENTA, INC.
- 16.2.4 EVOTEC SE
- 16.2.5 MEDGENOME LABS LTD.
- 16.2.6 CD GENOMICS
- 16.2.7 BIOGENITY
- 16.2.8 SAPIENT BIOANALYTICS, LLC
- 16.2.9 RAYBIOTECH, INC.
- 16.2.10 SOURCE BIOSCIENCE LTD.

17 RESEARCH METHODOLOGY

17.1 RESEARCH DATA
- 17.1.1 SECONDARY DATA
- 17.1.2 PRIMARY DATA
17.2 MARKET ESTIMATION METHODOLOGY
- 17.2.1 MARKET SIZE ESTIMATION
- 17.2.2 INSIGHTS OF PRIMARY EXPERTS
- 17.2.3 TOP-DOWN APPROACH
17.3 MARKET GROWTH RATE PROJECTIONS
17.4 MARKET BREAKDOWN AND DATA TRIANGULATION
17.5 RESEARCH ASSUMPTIONS
17.6 RESEARCH LIMITATIONS
17.7 RISK ANALYSIS

18 APPENDIX

18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS

Product Code: BT 10585

List of Tables

TABLE 1 MULTIOMICS MARKET: IMPACT ANALYSIS
TABLE 2 MULTIOMICS MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 3 MULTIOMICS MARKET: ROLE IN ECOSYSTEM
TABLE 4 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY TYPE, 2023-2025 (USD)
TABLE 5 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY TYPE, 2023-2025 (USD)
TABLE 6 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2023-2025 (USD)
TABLE 7 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY REGION, 2023-2025 (USD)
TABLE 8 IMPORT DATA FOR HS CODE 9027, 2021-2025, (USD THOUSAND)
TABLE 9 EXPORT DATA HS CODE 9027, 2021-2025 (USD THOUSAND)
TABLE 10 IMPORT VOLUME HS CODE 9027, 2021-2025 (TONS)
TABLE 11 EXPORT VOLUME HS CODE 9027, 2021-2025 (TONS)
TABLE 12 MULTIOMICS MARKET: KEY CONFERENCES & EVENTS, 2026-2027
TABLE 13 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 14 INDICATIVE LIST OF PATENTS IN MULTIOMICS MARKET, 2025-2026
TABLE 15 CASE STUDIES OF AI IMPLEMENTATION IN MULTIOMICS MARKET
TABLE 16 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MULTIOMICS MARKET
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 22 MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 23 MULTIOMICS PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 24 NORTH AMERICA: MULTIOMICS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 25 EUROPE: MULTIOMICS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 26 ASIA PACIFIC: MULTIOMICS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 27 LATIN AMERICA: MULTIOMICS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 28 MIDDLE EAST: MULTIOMICS PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 29 GCC COUNTRIES: MULTIOMICS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 30 MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 31 MULTIOMICS CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 32 NORTH AMERICA: MULTIOMICS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 33 EUROPE: MULTIOMICS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 34 ASIA PACIFIC: MULTIOMICS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 35 LATIN AMERICA: MULTIOMICS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 36 MIDDLE EAST: MULTIOMICS CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 37 GCC COUNTRIES: MULTIOMICS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 38 ASSAY KITS & REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 39 NORTH AMERICA: ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 40 EUROPE: ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 41 ASIA PACIFIC: ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 42 LATIN AMERICA: ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 43 MIDDLE EAST: ASSAY KITS & REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 44 GCC COUNTRIES: ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 45 OTHER CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 46 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 47 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 48 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 49 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 50 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 51 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 52 MULTIOMICS INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 53 NORTH AMERICA: MULTIOMICS INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 54 EUROPE: MULTIOMICS INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 55 ASIA PACIFIC: MULTIOMICS INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 56 LATIN AMERICA: MULTIOMICS INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 57 MIDDLE EAST: MULTIOMICS INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 58 GCC COUNTRIES: MULTIOMICS INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 59 MULTIOMICS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 60 NORTH AMERICA: MULTIOMICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 61 EUROPE: MULTIOMICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 62 ASIA PACIFIC: MULTIOMICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 63 LATIN AMERICA: MULTIOMICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 64 MIDDLE EAST: MULTIOMICS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 65 GCC COUNTRIES: MULTIOMICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 66 MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 67 SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 68 SEQUENCING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 69 NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 70 EUROPE: SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 71 ASIA PACIFIC: SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 72 LATIN AMERICA: SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 73 MIDDLE EAST: SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 74 GCC COUNTRIES: SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 75 LONG-READ SEQUENCING TECHNOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 76 LONG-READ SEQUENCING TECHNOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 77 NORTH AMERICA: LONG-READ SEQUENCING TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 78 EUROPE: LONG-READ SEQUENCING TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 79 ASIA PACIFIC: LONG-READ SEQUENCING TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 80 LATIN AMERICA: LONG-READ SEQUENCING TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 81 MIDDLE EAST: LONG-READ SEQUENCING TECHNOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 82 GCC COUNTRIES: LONG-READ SEQUENCING TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 83 NANOPORE SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 85 EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 86 ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 87 LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 88 MIDDLE EAST: NANOPORE SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 89 GCC COUNTRIES: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 90 SMRT SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 91 NORTH AMERICA: SMRT SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 92 EUROPE: SMRT SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 93 ASIA PACIFIC: SMRT SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 94 LATIN AMERICA: SMRT SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 95 MIDDLE EAST: SMRT SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 96 GCC COUNTRIES: SMRT SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 97 OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 98 NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 99 EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 100 ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 101 LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 102 MIDDLE EAST: OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 103 GCC COUNTRIES: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 104 PROTEOMICS TECHNOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 105 NORTH AMERICA: PROTEOMICS TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 106 EUROPE: PROTEOMICS TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 107 ASIA PACIFIC: PROTEOMICS TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 108 LATIN AMERICA: PROTEOMICS TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 109 MIDDLE EAST: PROTEOMICS TECHNOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 110 GCC COUNTRIES: PROTEOMICS TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 111 OTHER TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 112 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 113 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 114 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 115 LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 116 MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 117 GCC COUNTRIES: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 118 MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 119 SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 120 SINGLE-CELL OMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 121 NORTH AMERICA: SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 122 EUROPE: SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 123 ASIA PACIFIC: SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 124 LATIN AMERICA: SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 125 MIDDLE EAST: SINGLE-CELL OMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 126 GCC COUNTRIES: SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 127 SINGLE-CELL TRANSCRIPTOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 128 NORTH AMERICA: SINGLE-CELL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 129 EUROPE: SINGLE-CELL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 130 ASIA PACIFIC: SINGLE-CELL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 131 LATIN AMERICA: SINGLE-CELL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 132 MIDDLE EAST: SINGLE-CELL TRANSCRIPTOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 133 GCC COUNTRIES: SINGLE-CELL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 134 SINGLE-CELL EPIGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 135 NORTH AMERICA: SINGLE-CELL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 136 EUROPE: SINGLE-CELL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 137 ASIA PACIFIC: SINGLE-CELL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 138 LATIN AMERICA: SINGLE-CELL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 139 MIDDLE EAST: SINGLE-CELL EPIGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 140 GCC COUNTRIES: SINGLE-CELL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 141 SINGLE-CELL PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 142 NORTH AMERICA: SINGLE-CELL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 143 EUROPE: SINGLE-CELL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 144 ASIA PACIFIC: SINGLE-CELL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 145 LATIN AMERICA: SINGLE-CELL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 146 MIDDLE EAST: SINGLE-CELL PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 147 GCC COUNTRIES: SINGLE-CELL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 148 SINGLE-CELL GENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 149 NORTH AMERICA: SINGLE-CELL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 150 EUROPE: SINGLE-CELL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 151 ASIA PACIFIC: SINGLE-CELL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 152 LATIN AMERICA: SINGLE-CELL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 153 MIDDLE EAST: SINGLE-CELL GENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 154 GCC COUNTRIES: SINGLE-CELL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 155 OTHER SINGLE-CELL OMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 156 NORTH AMERICA: OTHER SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 157 EUROPE: OTHER SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 158 ASIA PACIFIC: OTHER SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 159 LATIN AMERICA: OTHER SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 160 MIDDLE EAST: OTHER SINGLE-CELL OMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 161 GCC COUNTRIES: OTHER SINGLE-CELL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 162 PROTEOMICS METHOD MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 163 PROTEOMICS METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 164 NORTH AMERICA: PROTEOMICS METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 165 EUROPE: PROTEOMICS METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 166 ASIA PACIFIC: PROTEOMICS METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 167 LATIN AMERICA: PROTEOMICS METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 168 MIDDLE EAST: PROTEOMICS METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 169 GCC COUNTRIES: PROTEOMICS METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 170 MS-BASED PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 171 NORTH AMERICA: MS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 172 EUROPE: MS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 173 ASIA PACIFIC: MS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 174 LATIN AMERICA: MS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 175 MIDDLE EAST: MS-BASED PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 176 GCC COUNTRIES: MS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 177 NGS-BASED PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 178 NORTH AMERICA: NGS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 179 EUROPE: NGS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 180 ASIA PACIFIC: NGS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 181 LATIN AMERICA: NGS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 182 MIDDLE EAST: NGS-BASED PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 183 GCC COUNTRIES: NGS-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 184 PCR-BASED PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 185 NORTH AMERICA: PCR-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 186 EUROPE: PCR-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 187 ASIA PACIFIC: PCR-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 188 LATIN AMERICA: PCR-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 189 MIDDLE EAST: PCR-BASED PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 190 GCC COUNTRIES: PCR-BASED PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 191 OTHER PROTEOMICS METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 192 NORTH AMERICA: OTHER PROTEOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 193 EUROPE: OTHER PROTEOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 194 ASIA PACIFIC: OTHER PROTEOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 195 LATIN AMERICA: OTHER PROTEOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 196 MIDDLE EAST: OTHER PROTEOMICS METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 197 GCC COUNTRIES: OTHER PROTEOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 198 SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 199 SPATIAL OMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 200 NORTH AMERICA: SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 201 EUROPE: SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 202 ASIA PACIFIC: SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 203 LATIN AMERICA: SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 204 MIDDLE EAST: SPATIAL OMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 205 GCC COUNTRIES: SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 206 SPATIAL TRANSCRIPTOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 207 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 208 EUROPE: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 209 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 210 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 211 MIDDLE EAST: SPATIAL TRANSCRIPTOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 212 GCC COUNTRIES: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 213 SPATIAL PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 214 NORTH AMERICA: SPATIAL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 215 EUROPE: SPATIAL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 216 ASIA PACIFIC: SPATIAL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 217 LATIN AMERICA: SPATIAL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 218 MIDDLE EAST: SPATIAL PROTEOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 219 GCC COUNTRIES: SPATIAL PROTEOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 220 SPATIAL EPIGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 221 NORTH AMERICA: SPATIAL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 222 EUROPE: SPATIAL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 223 ASIA PACIFIC: SPATIAL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 224 LATIN AMERICA: SPATIAL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 225 MIDDLE EAST: SPATIAL EPIGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 226 GCC COUNTRIES: SPATIAL EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 227 SPATIAL GENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 228 NORTH AMERICA: SPATIAL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 229 EUROPE: SPATIAL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 230 ASIA PACIFIC: SPATIAL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 231 LATIN AMERICA: SPATIAL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 232 MIDDLE EAST: SPATIAL GENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 233 GCC COUNTRIES: SPATIAL GENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 234 OTHER SPATIAL OMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 235 NORTH AMERICA: OTHER SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 236 EUROPE: OTHER SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 237 ASIA PACIFIC: OTHER SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 238 LATIN AMERICA: OTHER SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 239 MIDDLE EAST: OTHER SPATIAL OMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 240 GCC COUNTRIES: OTHER SPATIAL OMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 241 LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 242 LONG-READ & LONG-RANGE SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 243 NORTH AMERICA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 244 EUROPE: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 245 ASIA PACIFIC: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 246 LATIN AMERICA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 247 MIDDLE EAST: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 248 GCC COUNTRIES: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 249 LONG-READ SEQUENCING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 250 NORTH AMERICA: LONG-READ SEQUENCING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 251 EUROPE: LONG-READ SEQUENCING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 252 ASIA PACIFIC: LONG-READ SEQUENCING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 253 LATIN AMERICA: LONG-READ SEQUENCING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 254 MIDDLE EAST: LONG-READ SEQUENCING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 255 GCC COUNTRIES: LONG-READ SEQUENCING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 256 LONG-RANGE SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 257 NORTH AMERICA: LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 258 EUROPE: LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 259 ASIA PACIFIC: LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 260 LATIN AMERICA: LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 261 MIDDLE EAST: LONG-RANGE SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 262 GCC COUNTRIES: LONG-RANGE SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 263 OTHER LONG-READ & LONG-RANGE SEQUENCING METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 264 NORTH AMERICA: OTHER LONG-READ & LONG-RANGE SEQUENCING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 265 EUROPE: OTHER LONG-READ & LONG-RANGE SEQUENCING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 266 ASIA PACIFIC: OTHER LONG-READ & LONG-RANGE SEQUENCING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 267 LATIN AMERICA: OTHER LONG-READ & LONG-RANGE SEQUENCING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 268 MIDDLE EAST: OTHER LONG-READ & LONG-RANGE SEQUENCING METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 269 GCC COUNTRIES: OTHER LONG-READ & LONG-RANGE SEQUENCING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 270 EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 271 EPIGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 272 NORTH AMERICA: EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 273 EUROPE: EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 274 ASIA PACIFIC: EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 275 LATIN AMERICA: EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 276 MIDDLE EAST: EPIGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 277 GCC COUNTRIES: EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 278 SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 279 SEQUENCING-BASED EPIGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 280 NORTH AMERICA: SEQUENCING-BASED EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 281 EUROPE: SEQUENCING-BASED EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 282 ASIA PACIFIC: SEQUENCING-BASED EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 283 LATIN AMERICA: SEQUENCING-BASED EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 284 MIDDLE EAST: SEQUENCING-BASED EPIGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 285 GCC COUNTRIES: SEQUENCING-BASED EPIGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 286 DNA METHYLATION SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 287 NORTH AMERICA: DNA METHYLATION SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 288 EUROPE: DNA METHYLATION SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 289 ASIA PACIFIC: DNA METHYLATION SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 290 LATIN AMERICA: DNA METHYLATION SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 291 MIDDLE EAST: DNA METHYLATION SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 292 GCC COUNTRIES: DNA METHYLATION SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 293 CHROMATIN ACCESSIBILITY SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 294 NORTH AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 295 EUROPE: CHROMATIN ACCESSIBILITY SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 296 ASIA PACIFIC: CHROMATIN ACCESSIBILITY SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 297 LATIN AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 298 MIDDLE EAST: CHROMATIN ACCESSIBILITY SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 299 GCC COUNTRIES: CHROMATIN ACCESSIBILITY SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 300 HISTONE MODIFICATION PROFILING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 301 NORTH AMERICA: HISTONE MODIFICATION PROFILING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 302 EUROPE: HISTONE MODIFICATION PROFILING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 303 ASIA PACIFIC: HISTONE MODIFICATION PROFILING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 304 LATIN AMERICA: HISTONE MODIFICATION PROFILING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 305 MIDDLE EAST: HISTONE MODIFICATION PROFILING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 306 GCC COUNTRIES: HISTONE MODIFICATION PROFILING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 307 CHROMATIN INTERACTION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 308 NORTH AMERICA: CHROMATIN INTERACTION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 309 EUROPE: CHROMATIN INTERACTION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 310 ASIA PACIFIC: CHROMATIN INTERACTION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 311 LATIN AMERICA: CHROMATIN INTERACTION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 312 MIDDLE EAST: CHROMATIN INTERACTION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 313 GCC COUNTRIES: CHROMATIN INTERACTION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 314 OTHER EPIGENOMICS METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 315 NORTH AMERICA: OTHER EPIGENOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 316 EUROPE: OTHER EPIGENOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 317 ASIA PACIFIC: OTHER EPIGENOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 318 LATIN AMERICA: OTHER EPIGENOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 319 MIDDLE EAST: OTHER EPIGENOMICS METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 320 GCC COUNTRIES: OTHER EPIGENOMICS METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 321 OTHER METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 322 NORTH AMERICA: OTHER METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 323 EUROPE: OTHER METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 324 ASIA PACIFIC: OTHER METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 325 LATIN AMERICA: OTHER METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 326 MIDDLE EAST: OTHER METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 327 GCC COUNTRIES: OTHER METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 328 MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 329 SEQUENCING & ANALYSIS/SAMPLE CHARACTERIZATION MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 330 NORTH AMERICA: SEQUENCING & ANALYSIS/SAMPLE CHARACTERIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 331 EUROPE: SEQUENCING & ANALYSIS/SAMPLE CHARACTERIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 332 ASIA PACIFIC: SEQUENCING & ANALYSIS/SAMPLE CHARACTERIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 333 LATIN AMERICA: SEQUENCING & ANALYSIS/SAMPLE CHARACTERIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 334 MIDDLE EAST: SEQUENCING & ANALYSIS/SAMPLE CHARACTERIZATION MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 335 GCC COUNTRIES: SEQUENCING & ANALYSIS/SAMPLE CHARACTERIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 336 SAMPLE PREPARATION MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 337 NORTH AMERICA: SAMPLE PREPARATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 338 EUROPE: SAMPLE PREPARATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 339 ASIA PACIFIC: SAMPLE PREPARATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 340 LATIN AMERICA: SAMPLE PREPARATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 341 MIDDLE EAST: SAMPLE PREPARATION MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 342 GCC COUNTRIES: SAMPLE PREPARATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 343 DATA VISUALIZATION & ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 344 NORTH AMERICA: DATA VISUALIZATION & ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 345 EUROPE: DATA VISUALIZATION & ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 346 ASIA PACIFIC: DATA VISUALIZATION & ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 347 LATIN AMERICA: DATA VISUALIZATION & ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 348 MIDDLE EAST: DATA VISUALIZATION & ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 349 GCC COUNTRIES: DATA VISUALIZATION & ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 350 MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 351 ONCOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 352 NORTH AMERICA: ONCOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 353 EUROPE: ONCOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 354 ASIA PACIFIC: ONCOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 355 LATIN AMERICA: ONCOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 356 MIDDLE EAST: ONCOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 357 GCC COUNTRIES: ONCOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 358 DRUG DISCOVERY & DEVELOPMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 359 NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 360 EUROPE: DRUG DISCOVERY & DEVELOPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 361 ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 362 LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 363 MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 364 GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 365 IMMUNOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 366 NORTH AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 367 EUROPE: IMMUNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 368 ASIA PACIFIC: IMMUNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 369 LATIN AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 370 MIDDLE EAST: IMMUNOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 371 GCC COUNTRIES: IMMUNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 372 PRECISION MEDICINE MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 373 NORTH AMERICA: PRECISION MEDICINE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 374 EUROPE: PRECISION MEDICINE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 375 ASIA PACIFIC: PRECISION MEDICINE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 376 LATIN AMERICA: PRECISION MEDICINE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 377 MIDDLE EAST: PRECISION MEDICINE MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 378 GCC COUNTRIES: PRECISION MEDICINE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 379 BIOMARKER DISCOVERY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 380 NORTH AMERICA: BIOMARKER DISCOVERY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 381 EUROPE: BIOMARKER DISCOVERY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 382 ASIA PACIFIC: BIOMARKER DISCOVERY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 383 LATIN AMERICA: BIOMARKER DISCOVERY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 384 MIDDLE EAST: BIOMARKER DISCOVERY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 385 GCC COUNTRIES: BIOMARKER DISCOVERY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 386 CELL BIOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 387 NORTH AMERICA: CELL BIOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 388 EUROPE: CELL BIOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 389 ASIA PACIFIC: CELL BIOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 390 LATIN AMERICA: CELL BIOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 391 MIDDLE EAST: CELL BIOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 392 GCC COUNTRIES: CELL BIOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 393 TRANSLATIONAL RESEARCH MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 394 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 395 EUROPE: TRANSLATIONAL RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 396 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 397 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 398 MIDDLE EAST: TRANSLATIONAL RESEARCH MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 399 GCC COUNTRIES: TRANSLATIONAL RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 400 NEUROLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 401 NORTH AMERICA: NEUROLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 402 EUROPE: NEUROLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 403 ASIA PACIFIC: NEUROLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 404 LATIN AMERICA: NEUROLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 405 MIDDLE EAST: NEUROLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 406 GCC COUNTRIES: NEUROLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 407 CLINICAL DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 408 NORTH AMERICA: CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 409 EUROPE: CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 410 ASIA PACIFIC: CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 411 LATIN AMERICA: CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 412 MIDDLE EAST: CLINICAL DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 413 GCC COUNTRIES: CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 414 OTHER APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 415 NORTH AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 416 EUROPE: OTHER APPLICATIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 417 ASIA PACIFIC: OTHER APPLICATIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 418 LATIN AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 419 MIDDLE EAST: OTHER APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 420 GCC COUNTRIES: OTHER APPLICATIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 421 MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 422 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 423 NORTH AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 424 EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 425 ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 426 LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 427 MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 428 GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 429 ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 430 NORTH AMERICA: ACADEMIC & RESEARCH INSTITUTES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 431 EUROPE: ACADEMIC & RESEARCH INSTITUTES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 432 ASIA PACIFIC: ACADEMIC & RESEARCH INSTITUTES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 433 LATIN AMERICA: ACADEMIC & RESEARCH INSTITUTES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 434 MIDDLE EAST: ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 435 GCC COUNTRIES: ACADEMIC & RESEARCH INSTITUTES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 436 CROS & CDMOS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 437 NORTH AMERICA: CROS & CDMOS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 438 EUROPE: CROS & CDMOS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 439 ASIA PACIFIC: CROS & CDMOS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 440 LATIN AMERICA: CROS & CDMOS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 441 MIDDLE EAST: CROS & CDMOS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 442 GCC COUNTRIES: CROS & CDMOS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 443 HOSPITALS & DIAGNOSTIC/CLINICAL LABORATORIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 444 NORTH AMERICA: HOSPITALS & DIAGNOSTIC/CLINICAL LABORATORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 445 EUROPE: HOSPITALS & DIAGNOSTIC/CLINICAL LABORATORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 446 ASIA PACIFIC: HOSPITALS & DIAGNOSTIC/CLINICAL LABORATORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 447 LATIN AMERICA: HOSPITALS & DIAGNOSTIC/CLINICAL LABORATORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 448 MIDDLE EAST: HOSPITALS & DIAGNOSTIC/CLINICAL LABORATORIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 449 GCC COUNTRIES: HOSPITALS & DIAGNOSTIC/CLINICAL LABORATORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 450 MULTIOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 451 NORTH AMERICA: MULTIOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 452 NORTH AMERICA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 453 NORTH AMERICA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 454 NORTH AMERICA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 455 NORTH AMERICA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 456 NORTH AMERICA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 457 NORTH AMERICA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 458 NORTH AMERICA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 459 NORTH AMERICA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 460 NORTH AMERICA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 461 NORTH AMERICA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 462 NORTH AMERICA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 463 NORTH AMERICA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 464 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 465 NORTH AMERICA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 466 NORTH AMERICA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 467 NORTH AMERICA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 468 US: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 469 US: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 470 US: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 471 US: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 472 US: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 473 US: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 474 US: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 475 US: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 476 US: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 477 US: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 478 US: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 479 US: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 480 US: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 481 US: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 482 US: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 483 US: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 484 CANADA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 485 CANADA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 486 CANADA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 487 CANADA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 488 CANADA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 489 CANADA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 490 CANADA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 491 CANADA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 492 CANADA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 493 CANADA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 494 CANADA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 495 CANADA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 496 CANADA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 497 CANADA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 498 CANADA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 499 CANADA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 500 EUROPE: MULTIOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 501 EUROPE: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 502 EUROPE: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 503 EUROPE: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 504 EUROPE: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 505 EUROPE: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 506 EUROPE: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 507 EUROPE: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 508 EUROPE: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 509 EUROPE: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 510 EUROPE: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 511 EUROPE: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 512 EUROPE: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 513 EUROPE: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 514 EUROPE: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 515 EUROPE: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 516 EUROPE: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 517 GERMANY: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 518 GERMANY: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 519 GERMANY: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 520 GERMANY: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 521 GERMANY: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 522 GERMANY: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 523 GERMANY: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 524 GERMANY: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 525 GERMANY: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 526 GERMANY: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 527 GERMANY: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 528 GERMANY: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 529 GERMANY: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 530 GERMANY: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 531 GERMANY: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 532 GERMANY: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 533 UK: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 534 UK: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 535 UK: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 536 UK: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 537 UK: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 538 UK: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 539 UK: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 540 UK: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 541 UK: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 542 UK: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 543 UK: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 544 UK: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 545 UK: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 546 UK: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 547 UK: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 548 UK: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 549 FRANCE: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 550 FRANCE: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 551 FRANCE: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 552 FRANCE: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 553 FRANCE: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 554 FRANCE: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 555 FRANCE: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 556 FRANCE: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 557 FRANCE: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 558 FRANCE: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 559 FRANCE: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 560 FRANCE: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 561 FRANCE: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 562 FRANCE: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 563 FRANCE: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 564 FRANCE: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 565 ITALY: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 566 ITALY: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 567 ITALY: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 568 ITALY: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 569 ITALY: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 570 ITALY: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 571 ITALY: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 572 ITALY: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 573 ITALY: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 574 ITALY: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 575 ITALY: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 576 ITALY: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 577 ITALY: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 578 ITALY: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 579 ITALY: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 580 ITALY: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 581 SPAIN: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 582 SPAIN: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 583 SPAIN: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 584 SPAIN: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 585 SPAIN: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 586 SPAIN: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 587 SPAIN: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 588 SPAIN: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 589 SPAIN: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 590 SPAIN: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 591 SPAIN: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 592 SPAIN: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 593 SPAIN: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 594 SPAIN: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 595 SPAIN: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 596 SPAIN: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 597 REST OF EUROPE: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 598 REST OF EUROPE: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 599 REST OF EUROPE: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 600 REST OF EUROPE: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 601 REST OF EUROPE: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 602 REST OF EUROPE: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 603 REST OF EUROPE: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 604 REST OF EUROPE: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 605 REST OF EUROPE: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 606 REST OF EUROPE: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 607 REST OF EUROPE: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 608 REST OF EUROPE: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 609 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 610 REST OF EUROPE: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 611 REST OF EUROPE: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 612 REST OF EUROPE: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 613 ASIA PACIFIC: MULTIOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 614 ASIA PACIFIC: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 615 ASIA PACIFIC: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 616 ASIA PACIFIC: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 617 ASIA PACIFIC: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 618 ASIA PACIFIC: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 619 ASIA PACIFIC: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 620 ASIA PACIFIC: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 621 ASIA PACIFIC: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 622 ASIA PACIFIC: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 623 ASIA PACIFIC: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 624 ASIA PACIFIC: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 625 ASIA PACIFIC: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 626 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 627 ASIA PACIFIC: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 628 ASIA PACIFIC: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 629 ASIA PACIFIC: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 630 CHINA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 631 CHINA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 632 CHINA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 633 CHINA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 634 CHINA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 635 CHINA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 636 CHINA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 637 CHINA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 638 CHINA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 639 CHINA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 640 CHINA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 641 CHINA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 642 CHINA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 643 CHINA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 644 CHINA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 645 CHINA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 646 JAPAN: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 647 JAPAN: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 648 JAPAN: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 649 JAPAN: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 650 JAPAN: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 651 JAPAN: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 652 JAPAN: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 653 JAPAN: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 654 JAPAN: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 655 JAPAN: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 656 JAPAN: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 657 JAPAN: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 658 JAPAN: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 659 JAPAN: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 660 JAPAN: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 661 JAPAN: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 662 SOUTH KOREA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 663 SOUTH KOREA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 664 SOUTH KOREA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 665 SOUTH KOREA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 666 SOUTH KOREA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 667 SOUTH KOREA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 668 SOUTH KOREA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 669 SOUTH KOREA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 670 SOUTH KOREA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 671 SOUTH KOREA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 672 SOUTH KOREA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 673 SOUTH KOREA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 674 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 675 SOUTH KOREA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 676 SOUTH KOREA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 677 SOUTH KOREA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 678 INDIA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 679 INDIA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 680 INDIA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 681 INDIA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 682 INDIA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 683 INDIA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 684 INDIA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 685 INDIA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 686 INDIA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 687 INDIA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 688 INDIA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 689 INDIA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 690 INDIA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 691 INDIA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 692 INDIA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 693 INDIA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 694 AUSTRALIA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 695 AUSTRALIA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 696 AUSTRALIA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 697 AUSTRALIA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 698 AUSTRALIA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 699 AUSTRALIA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 700 AUSTRALIA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 701 AUSTRALIA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 702 AUSTRALIA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 703 AUSTRALIA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 704 AUSTRALIA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 705 AUSTRALIA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 706 AUSTRALIA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 707 AUSTRALIA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 708 AUSTRALIA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 709 AUSTRALIA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 710 REST OF ASIA PACIFIC: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 711 REST OF ASIA PACIFIC: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 712 REST OF ASIA PACIFIC: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 713 REST OF ASIA PACIFIC: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 714 REST OF ASIA PACIFIC: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 715 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 716 REST OF ASIA PACIFIC: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 717 REST OF ASIA PACIFIC: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 718 REST OF ASIA PACIFIC: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 719 REST OF ASIA PACIFIC: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 720 REST OF ASIA PACIFIC: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 721 REST OF ASIA PACIFIC: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 722 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 723 REST OF ASIA PACIFIC: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 724 REST OF ASIA PACIFIC: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 725 REST OF ASIA PACIFIC: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 726 LATIN AMERICA: MULTIOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 727 LATIN AMERICA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 728 LATIN AMERICA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 729 LATIN AMERICA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 730 LATIN AMERICA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 731 LATIN AMERICA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 732 LATIN AMERICA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 733 LATIN AMERICA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 734 LATIN AMERICA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 735 LATIN AMERICA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 736 LATIN AMERICA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 737 LATIN AMERICA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 738 LATIN AMERICA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 739 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 740 LATIN AMERICA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 741 LATIN AMERICA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 742 LATIN AMERICA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 743 BRAZIL: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 744 BRAZIL: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 745 BRAZIL: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 746 BRAZIL: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 747 BRAZIL: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 748 BRAZIL: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 749 BRAZIL: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 750 BRAZIL: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 751 BRAZIL: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 752 BRAZIL: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 753 BRAZIL: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 754 BRAZIL: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 755 BRAZIL: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 756 BRAZIL: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 757 BRAZIL: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 758 BRAZIL: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 759 REST OF LATIN AMERICA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 760 REST OF LATIN AMERICA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 761 REST OF LATIN AMERICA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 762 REST OF LATIN AMERICA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 763 REST OF LATIN AMERICA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 764 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 765 REST OF LATIN AMERICA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 766 REST OF LATIN AMERICA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 767 REST OF LATIN AMERICA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 768 REST OF LATIN AMERICA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 769 REST OF LATIN AMERICA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 770 REST OF LATIN AMERICA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 771 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 772 REST OF LATIN AMERICA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 773 REST OF LATIN AMERICA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 774 REST OF LATIN AMERICA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 775 MIDDLE EAST: MULTIOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 776 MIDDLE EAST: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 777 MIDDLE EAST: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 778 MIDDLE EAST: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 779 MIDDLE EAST: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 780 MIDDLE EAST: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 781 MIDDLE EAST: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 782 MIDDLE EAST: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 783 MIDDLE EAST: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 784 MIDDLE EAST: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 785 MIDDLE EAST: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 786 MIDDLE EAST: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 787 MIDDLE EAST: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 788 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 789 MIDDLE EAST: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 790 MIDDLE EAST: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 791 MIDDLE EAST: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 792 GCC COUNTRIES: MULTIOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 793 GCC COUNTRIES: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 794 GCC COUNTRIES: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 795 GCC COUNTRIES: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 796 GCC COUNTRIES: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 797 GCC COUNTRIES: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 798 GCC COUNTRIES: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 799 GCC COUNTRIES: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 800 GCC COUNTRIES: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 801 GCC COUNTRIES: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 802 GCC COUNTRIES: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 803 GCC COUNTRIES: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 804 GCC COUNTRIES: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 805 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 806 GCC COUNTRIES: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 807 GCC COUNTRIES: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 808 GCC COUNTRIES: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 809 SAUDI ARABIA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 810 SAUDI ARABIA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 811 SAUDI ARABIA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 812 SAUDI ARABIA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 813 SAUDI ARABIA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 814 SAUDI ARABIA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 815 SAUDI ARABIA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 816 SAUDI ARABIA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 817 SAUDI ARABIA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 818 SAUDI ARABIA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 819 SAUDI ARABIA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 820 SAUDI ARABIA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 821 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 822 SAUDI ARABIA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 823 SAUDI ARABIA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 824 SAUDI ARABIA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 825 UAE: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 826 UAE: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 827 UAE: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 828 UAE: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 829 UAE: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 830 UAE: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 831 UAE: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 832 UAE: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 833 UAE: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 834 UAE: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 835 UAE: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 836 UAE: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 837 UAE: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 838 UAE: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 839 UAE: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 840 UAE: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 841 REST OF GCC COUNTRIES: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 842 REST OF GCC COUNTRIES: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 843 REST OF GCC COUNTRIES: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 844 REST OF GCC COUNTRIES: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 845 REST OF GCC COUNTRIES: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 846 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 847 REST OF GCC COUNTRIES: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 848 REST OF GCC COUNTRIES: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 849 REST OF GCC COUNTRIES: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 850 REST OF GCC COUNTRIES: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 851 REST OF GCC COUNTRIES: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 852 REST OF GCC COUNTRIES: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 853 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 854 REST OF GCC COUNTRIES: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 855 REST OF GCC COUNTRIES: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 856 REST OF GCC COUNTRIES: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 857 REST OF MIDDLE EAST: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 858 REST OF MIDDLE EAST: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 859 REST OF MIDDLE EAST: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 860 REST OF MIDDLE EAST: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 861 REST OF MIDDLE EAST: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 862 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 863 REST OF MIDDLE EAST: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 864 REST OF MIDDLE EAST: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 865 REST OF MIDDLE EAST: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 866 REST OF MIDDLE EAST: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 867 REST OF MIDDLE EAST: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 868 REST OF MIDDLE EAST: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 869 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 870 REST OF MIDDLE EAST: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 871 REST OF MIDDLE EAST: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 872 REST OF MIDDLE EAST: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 873 AFRICA: MULTIOMICS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 874 AFRICA: MULTIOMICS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 875 AFRICA: MULTIOMICS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 876 AFRICA: MULTIOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 877 AFRICA: SINGLE-CELL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 878 AFRICA: PROTEOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 879 AFRICA: SPATIAL OMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 880 AFRICA: LONG-READ & LONG-RANGE SEQUENCING MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 881 AFRICA: EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 882 AFRICA: SEQUENCING-BASED EPIGENOMICS MARKET, BY METHOD, 2024-2031 (USD MILLION)
TABLE 883 AFRICA: MULTIOMICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 884 AFRICA: SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 885 AFRICA: LONG-READ SEQUENCING MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 886 AFRICA: MULTIOMICS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 887 AFRICA: MULTIOMICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 888 AFRICA: MULTIOMICS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 889 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS
TABLE 890 MULTIOMICS MARKET: DEGREE OF COMPETITION
TABLE 891 MULTIOMICS MARKET: REGION FOOTPRINT
TABLE 892 MULTIOMICS MARKET: OFFERING FOOTPRINT
TABLE 893 MULTIOMICS MARKET: TECHNOLOGY FOOTPRINT
TABLE 894 MULTIOMICS MARKET: WORKFLOW FOOTPRINT
TABLE 895 MULTIOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 896 MULTIOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 897 MULTIOMICS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 898 MULTIOMICS MARKET: DEALS, JANUARY 2023-JULY 2026
TABLE 899 MULTIOMICS MARKET: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 900 10X GENOMICS: COMPANY OVERVIEW
TABLE 901 10X GENOMICS: PRODUCTS & SERVICES OFFERED
TABLE 902 10X GENOMICS, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 903 10X GENOMICS, INC.: DEALS, JANUARY 2023-JULY 2026
TABLE 904 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 905 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
TABLE 906 THERMO FISHER SCIENTIFIC INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 907 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023-JULY 2026
TABLE 908 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 909 ILLUMINA, INC.: PRODUCTS & SERVICES OFFERED
TABLE 910 ILLUMINA, INC: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 911 ILLUMINA, INC.: DEALS, JANUARY 2023-JULY 2026
TABLE 912 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
TABLE 913 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS & SERVICES OFFERED
TABLE 914 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2023-JULY 2026
TABLE 915 OXFORD NANOPORE TECHNOLOGIES PLC: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 916 BRUKER: COMPANY OVERVIEW
TABLE 917 BRUKER: PRODUCTS & SERVICES OFFERED
TABLE 918 BRUKER : PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 919 BRUKER : DEALS, JANUARY 2023-JULY 2026
TABLE 920 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY OVERVIEW
TABLE 921 PACBIO.: PRODUCTS & SERVICES OFFERED
TABLE 922 PACBIO.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 923 PACBIO.: DEALS, JANUARY 2023-JULY 2026
TABLE 924 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 925 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 926 DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 927 DANAHER CORPORATION: DEALS, JANUARY 2023-JULY 2026
TABLE 928 VIZGEN, INC.: COMPANY OVERVIEW
TABLE 929 VIZGEN, INC.: PRODUCTS & SERVICES OFFERED
TABLE 930 VIZGEN, INC.: DEALS, JANUARY 2023-JULY 2026
TABLE 931 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 932 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 933 AGILENT TECHNOLOGIES, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 934 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023-JULY 2026
TABLE 935 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 936 BIOGNOSYS: COMPANY OVERVIEW
TABLE 937 BIOGNOSYS: PRODUCTS & SERVICES OFFERED
TABLE 938 BIOGNOSYS: DEALS, JANUARY 2023-JULY 2026
TABLE 939 MERCK KGAA: COMPANY OVERVIEW
TABLE 940 MERCK KGAA: PRODUCTS & SERVICES OFFERED
TABLE 941 MERCK KGAA: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 942 QIAGEN: COMPANY OVERVIEW
TABLE 943 QIAGEN: PRODUCTS & SERVICES OFFERED
TABLE 944 QIAGEN: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 945 QIAGEN: DEALS, JANUARY 2023-JULY 2026
TABLE 946 QIAGEN: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 947 REVVITY: COMPANY OVERVIEW
TABLE 948 REVVITY: PRODUCTS & SERVICES OFFERED
TABLE 949 REVVITY: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 950 REVVITY: DEALS, JANUARY 2023-JULY 2026
TABLE 951 WATERS CORPORATION: COMPANY OVERVIEW
TABLE 952 WATERS CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 953 WATERS CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 954 WATERS CORPORATION: DEALS, JANUARY 2023-JULY 2026
TABLE 955 WATERS CORPORATION: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 956 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 957 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 958 BIO-RAD LABORATORIES, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 959 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023-JULY 2026
TABLE 960 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 961 TAKARA BIO INC.: PRODUCTS & SERVICES OFFERED
TABLE 962 TAKARA BIO INC.: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 963 METABOLON, INC.: COMPANY OVERVIEW
TABLE 964 METABOLON, INC.: PRODUCTS & SERVICES OFFERED
TABLE 965 METABOLON, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-JULY 2026
TABLE 966 BGI GENOMICS CO., LTD.: COMPANY OVERVIEW
TABLE 967 NOVOGENE CO., LTD.: COMPANY OVERVIEW
TABLE 968 AZENTA, INC.: COMPANY OVERVIEW
TABLE 969 EVOTEC SE: COMPANY OVERVIEW
TABLE 970 MEDGENOME LABS LTD.: COMPANY OVERVIEW
TABLE 971 CD GENOMICS: COMPANY OVERVIEW
TABLE 972 BIOGENITY: COMPANY OVERVIEW
TABLE 973 SAPIENT BIOANALYTICS, LLC: COMPANY OVERVIEW
TABLE 974 RAYBIOTECH, INC.: COMPANY OVERVIEW
TABLE 975 SOURCE BIOSCIENCE LTD.: COMPANY OVERVIEW
TABLE 976 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS

List of Figures

FIGURE 1 MARKETS COVERED AND REGIONS CONSIDERED
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL MULTIOMICS MARKET, 2024-2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MULTIOMICS MARKET, 2023-2026
FIGURE 5 DISRUPTIONS INFLUENCING THE GROWTH OF MULTIOMICS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN MULTIOMICS MARKET, 2026-2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MULTIOMICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8 RAPID ADOPTION OF SINGLE-CELL AND SPATIAL MULTIOMICS TO DRIVE MARKET
FIGURE 9 PRODUCTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
FIGURE 10 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 11 PRODUCTS TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 12 MULTIOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13 MULTIOMICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14 MULTIOMICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 15 MULTIOMICS MARKET: ECOSYSTEM ANALYSIS
FIGURE 16 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY TYPE, 2023-2025 (USD)
FIGURE 17 AVERAGE SELLING PRICE OF CONSUMABLES, 2023- 2025 (USD)
FIGURE 18 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2025 (USD)
FIGURE 19 AVERAGE SELLING PRICE OF CONSUMABLES, BY REGION, 2025 (USD)
FIGURE 20 MULTIOMICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 21 INVESTMENT/FUNDING ACTIVITY IN MULTIOMICS MARKET
FIGURE 22 TOP APPLICANTS/OWNERS (COMPANIES) FOR MULTIOMICS PATENTS, 2015-2025
FIGURE 23 IMPACT OF AI/GEN AI ON MULTIOMICS MARKET
FIGURE 24 NORTH AMERICA: MULTIOMICS MARKET SNAPSHOT
FIGURE 25 ASIA PACIFIC: MULTIOMICS MARKET SNAPSHOT
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS, 2021-2025 (USD MILLION)
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 28 MULTIOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 29 MULTIOMICS MARKET: COMPANY FOOTPRINT
FIGURE 30 MULTIOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 31 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 32 EV/EBITDA OF KEY VENDORS
FIGURE 33 MULTIOMICS MARKET: BRAND/PRODUCT COMPARISON
FIGURE 34 10X GENOMICS: COMPANY SNAPSHOT (2025)
FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 36 ILLUMINA, INC.: COMPANY SNAPSHOT (2025)
FIGURE 37 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2025)
FIGURE 38 BRUKER: COMPANY SNAPSHOT (2025)
FIGURE 39 PACBIO.: COMPANY SNAPSHOT (2025)
FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2025)
FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2025)
FIGURE 44 REVVITY: COMPANY SNAPSHOT (2025)
FIGURE 45 WATERS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 46 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 47 TAKARA BIO INC.: COMPANY SNAPSHOT (2025)
FIGURE 48 RESEARCH DESIGN
FIGURE 49 MULTIOMICS MARKET: BREAKDOWN OF PRIMARIES
FIGURE 50 MULTIOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
FIGURE 51 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025
FIGURE 52 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC. (2025)
FIGURE 53 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 54 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 55 MULTIOMICS MARKET CAGR PROJECTIONS
FIGURE 56 DATA TRIANGULATION METHODOLOGY

Multiomics Market by Offerings [Product (Instrument, Kits, Reagents), Service], Method (Epigenomics, Single Cell, Spatial), Technology [Sequencing, Proteomics (NGS, PCR, MS)], Workflow (Sample Prep), Application, Competition - Global Forecast to 2031

Description

Table of Contents

List of Tables

The primary interviews conducted for this report can be categorized as follows:

The report provides insights into the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

4 MARKET OVERVIEW

5 INDUSTRY TRENDS

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

8 MULTIOMICS MARKET, BY OFFERING

9 MULTIOMICS MARKET, BY TECHNOLOGY

10 MULTIOMICS MARKET, BY METHOD

11 MULTIOMICS MARKET, BY WORKFLOW

12 MULTIOMICS MARKET, BY APPLICATION

13 MULTIOMICS MARKET, BY END USER

14 MULTIOMICS MARKET, BY REGION

15 COMPETITIVE LANDSCAPE

16 COMPANY PROFILES

17 RESEARCH METHODOLOGY

18 APPENDIX

List of Tables

List of Figures